Nordlandssykehuset HF
- Address
- lock Available on a paid plan
Bacterial Infections and Mycoses
The department is assessing new antimicrobial strategies for lower respiratory tract infection and evaluating the safety of amoxicillin versus placebo in preschool children with pneumonia.
- Lower respiratory tract infection
- Pediatric pneumonia
- Antibiotic stewardship programs
Nordlandssykehuset HF currently supports a portfolio of 23 trials with 27 investigators, accelerating access to effective treatments for bacterial and fungal diseases.
Cardiovascular Diseases
Research emphasizes rapid intervention for acute myocardial infarction and intensive lipid lowering to manage high LDL‑C in patients with genetic hypercholesterolemia.
- Acute myocardial infarction
- Hypercholesterolemia
- Heterozygous familial hypercholesterolemia
- Hypertension
Ongoing studies test novel oral agents and combination therapies to reduce cardiovascular events and improve long‑term heart health.
Immune System Diseases
Trials target autoimmune conditions such as rheumatoid arthritis and multiple sclerosis, exploring proactive therapeutic drug monitoring and biologic switching to sustain disease control.
- Rheumatoid arthritis
- Multiple sclerosis
- Chronic migraine
- Cluster headache
The site leverages individualized dosing strategies to keep inflammation in check and improve patient quality of life.
Musculoskeletal Diseases
Investigations focus on reducing joint inflammation and pain, evaluating biologics and targeted agents to achieve sustained remission in inflammatory arthritis.
- Rheumatoid arthritis
- Joint inflammation
- Biologic therapy optimization
Patient‑centred outcomes guide therapeutic decisions, aiming for functional improvement and reduced disability.
Neoplasms
A comprehensive oncology program tests targeted and immunotherapies for breast cancer, non‑small cell lung cancer, and melanoma, striving to increase pathological complete response and overall survival.
- Advanced melanoma
- HER2‑positive breast cancer
- Non‑small cell lung cancer
- Small‑cell lung cancer
- Pancreatic ductal cancer
- Multiple myeloma
Precision medicine aligns genomic markers with drug selection, expanding options for hard‑to‑treat and rare tumors.
Nervous System Diseases
Neurology trials address neurodegenerative and headache disorders, testing novel agents to slow progression in amyotrophic lateral sclerosis and relieve symptoms of chronic migraine.
- Amyotrophic lateral sclerosis
- Chronic migraine
- Cluster headache
- Multiple sclerosis
The department aims to provide disease‑modifying therapies where few options currently exist.
Respiratory Tract Diseases
Clinical work evaluates therapies for chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis, seeking to preserve lung capacity and reduce exacerbations.
- Chronic obstructive pulmonary disease
- Idiopathic pulmonary fibrosis
- Lower respiratory tract infection
- Severe pneumonia
Trials assess anti‑fibrotic agents, inhaled therapies, and anti‑inflammatory strategies to improve respiratory outcomes.
Metabolism
Metabolic studies focus on type 2 diabetes, kidney protection, and cholesterol control, testing combination regimens that address organ preservation and cardiovascular risk.
- Type 2 diabetes
- Chronic kidney disease
- Hypercholesterolemia
- Hypertension
Research integrates metabolic control with cardiovascular protection to improve long‑term health.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 of 10 therapeutic areas and 15 of 106 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 104 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 16 by active trials.
- 1Oslo University Hospital HF4active
lock +15 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB6trials
lock +7 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 112 other sites in Norway
Therapeutic Area Benchmark — Norway
Select a therapeutic area to compare against other sites in Norway.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Norway
Market Share
Country: Norway
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Nordlandssykehuset HF
lock Showing 1 of 35 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Multicenter Non-Inferiority Trial Comparing Rituximab and Ocrelizumab in Patients with Active Relapsing-Remitting Multiple Sclerosis Aged 18-60 Years | Helse Bergen HF | Phase III | Recruiting | Oct 2020 | — |
IMP list
lock Showing 1 of 106 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Sodium Chloride | 4 | Unknown | 2019-10-01 | 2025-07-08 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.